this criterion eliminated 28 to 50 per cent of the patients with bladder cancer and 73 per cent of those who had undergone nephrectomy for renal carcinoma , which , obviously , limits the value of beta-2-microglobulin measurement for the surveillance in these cancers .
C0007134
renal carcinoma
C0006826
cancers